Medicon Hellas S.A. Market Cap ($12.15 Million)
Market Cap & Net Worth: Medicon Hellas S.A. (MEDIC)
Medicon Hellas S.A. market cap. Medicon Hellas S.A. (AT:MEDIC) has a market capitalization of $12.15 Million (€10.40 Million) as of October 31, 2026. Listed on the AT stock exchange, this Greece-based company holds position #26480 globally and #96 in its home market, demonstrating a 1.97% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Medicon Hellas S.A.'s stock price €3.11 by its total outstanding shares 4419616 (4.42 Million).
Medicon Hellas S.A. Market Cap History (2015–2026)
Medicon Hellas S.A. market cap history from 2015 to 2026. Data shows growth from $2.31 Million to $16.07 Million (20.63% CAGR). Check Medicon Hellas S.A. share price for real-time trading data and today's change.
Medicon Hellas S.A. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Medicon Hellas S.A.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see Medicon Hellas S.A. cash conversion from operations for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
0.88x
Medicon Hellas S.A.'s market cap is 0.88 times its annual revenue
Latest Price to Earnings (P/E) Ratio
7.25x
Medicon Hellas S.A.'s market cap is 7.25 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $2.31 Million | $11.46 Million | $1.67 Million | 0.20x | 1.38x |
| 2016 | $1.54 Million | $13.01 Million | $1.17 Million | 0.12x | 1.32x |
| 2017 | $4.27 Million | $12.70 Million | $1.72 Million | 0.34x | 2.49x |
| 2018 | $5.71 Million | $13.77 Million | $1.83 Million | 0.41x | 3.12x |
| 2019 | $11.81 Million | $13.45 Million | $775.17K | 0.88x | 15.24x |
| 2020 | $9.43 Million | $15.27 Million | $756.60K | 0.62x | 12.47x |
| 2021 | $24.23 Million | $21.51 Million | $3.04 Million | 1.13x | 7.97x |
| 2022 | $18.37 Million | $20.77 Million | $2.53 Million | 0.88x | 7.25x |
Competitor Companies of MEDIC by Market Capitalization
Companies near Medicon Hellas S.A. in the global market cap rankings as of October 31, 2026. See Medicon Hellas S.A. (MEDIC) net asset quality to understand what proportion of total assets are financed by equity.
Key companies related to Medicon Hellas S.A. by market ranking:
- Lavipharm S.A (AT:LAVI): Ranked #14837 globally with a market cap of $287.04 Million USD ( €245.52 Million EUR).
- CBI Co. Ltd (KQ:013720): Ranked #26471 globally with a market cap of $12.25 Million USD ( ₩18.08 Billion KRW).
- iZafe Group AB Series B (ST:IZAFE-B): Ranked #26481 globally with a market cap of $12.15 Million USD ( Skr112.87 Million SEK).
- Medience Co. LTD (KQ:014100): Ranked #26482 globally with a market cap of $12.14 Million USD ( ₩17.91 Billion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #14837 | Lavipharm S.A | AT:LAVI | $287.04 Million | €1.53 |
| #26471 | CBI Co. Ltd | KQ:013720 | $12.25 Million | ₩2330.00 |
| #26481 | iZafe Group AB Series B | ST:IZAFE-B | $12.15 Million | Skr0.28 |
| #26482 | Medience Co. LTD | KQ:014100 | $12.14 Million | ₩1585.00 |
Market Capitalization of Medicon Hellas S.A. (2015–2026)
Market capitalization of Medicon Hellas S.A. from 2015 to today. Between 2015 and today, Medicon Hellas S.A.'s market cap moved from $2.31 Million to $ 16.07 Million, with a yearly change of 20.63%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €16.07 Million | +22.92% |
| 2025 | €13.07 Million | +17.13% |
| 2024 | €11.16 Million | -35.14% |
| 2023 | €17.21 Million | -6.32% |
| 2022 | €18.37 Million | -24.18% |
| 2021 | €24.23 Million | +156.84% |
| 2020 | €9.43 Million | -20.17% |
| 2019 | €11.81 Million | +106.95% |
| 2018 | €5.71 Million | +33.72% |
| 2017 | €4.27 Million | +177.47% |
| 2016 | €1.54 Million | -33.35% |
| 2015 | €2.31 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 30th, 2026 the market cap of Medicon Hellas S.A. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $12.15 Million USD |
| MoneyControl | $12.15 Million USD |
| MarketWatch | $12.15 Million USD |
| marketcap.company | $12.15 Million USD |
| Reuters | $12.15 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Medicon Hellas S.A.
Medicon Hellas S.A. operates in the diagnostics industry. The company offers instruments, tests, and procedures for public and private hospitals, primary care centers, diagnostic centers, and private laboratories in Greece and internationally. The company distributes various analyzer sysytem for chemistry, immunochemistry and hematology labs, intensive care units, and point-of-care systems. It al… Read more